Here, we first corroborated the high expression of COL6A1, COL6A2, and COL6A3 within a subset of ECM-related genes in different GBM patients’ datasets, compared to lower-grade tumors and normal brain tissues. The gene discussed is COL6A3; the disease is glioblastoma.